Related references
Note: Only part of the references are listed.c-Met expression is associated with time to recurrence in patients with glioblastoma multiforme
Wei Liu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2011)
HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma
Rong Bu et al.
LABORATORY INVESTIGATION (2011)
Targeting the MET oncogene in cancer and metastases
Giulia M. Stella et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Monovalency Unleashes the Full Therapeutic Potential of the DN-30 Anti-Met Antibody
Giovanni Pacchiana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
A Disintegrin and Metalloproteinase-10 (ADAM-10) Mediates DN30 Antibody-induced Shedding of the Met Surface Receptor
Florian Schelter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
TAK-701, a Humanized Monoclonal Antibody to Hepatocyte Growth Factor, Reverses Gefitinib Resistance Induced by Tumor-Derived HGF in Non-Small Cell Lung Cancer with an EGFR Mutation
Wataru Okamoto et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Prognostic Significance of c-Met Expression in Glioblastomas
Doo-Sik Kong et al.
CANCER (2009)
Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
Joseph Paul Eder et al.
CLINICAL CANCER RESEARCH (2009)
A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo
Timothy E. Adams et al.
GROWTH FACTORS (2009)
Antibodies specifically targeting a locally misfolded region of tumor associated EGFR
Thomas P. J. Garrett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The Plasticity of Oncogene Addiction: Implications for Targeted Therapies Directed to Receptor Tyrosine Kinases
Vinochani Pillay et al.
NEOPLASIA (2009)
MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival
Hongkui Jin et al.
CANCER RESEARCH (2008)
Drug development of MET inhibitors: targeting oncogene addiction and expedience
Paolo M. Comoglio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
C-met must translocate to the nucleus to initiate calcium signals
Dawidson A. Gomes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Derailed endocytosis: an emerging feature of cancer
Yaron Mosesson et al.
NATURE REVIEWS CANCER (2008)
FireDock: Fast interaction refinement in molecular docking
Nelly Andrusier et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Inference of macromolecular assemblies from crystalline state
Evgeny Krissinel et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
A novel one-armed anti-c-met antibody inhibits glioblastoma growth in vivo
Tobias Martens et al.
CLINICAL CANCER RESEARCH (2006)
Ab-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activity
A Petrelli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts
KJ Kim et al.
CLINICAL CANCER RESEARCH (2006)
Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors
T Burgess et al.
CANCER RESEARCH (2006)
Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis
R Abounader et al.
NEURO-ONCOLOGY (2005)
Crystal structure of the HGF β-chain in complex with the Sema domain of the Met receptor
J Stamos et al.
EMBO JOURNAL (2004)
Met, metastasis, motility and more
C Birchmeier et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Hepatocyte growth factor/scatter factor facilitates migration of GN-11 immortalized LHRH neurons
P Giacobini et al.
ENDOCRINOLOGY (2002)
Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models
B Cao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
